https://scholars.lib.ntu.edu.tw/handle/123456789/623271
標題: | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | 作者: | Teng, Wei Chang, Ting-Tsung Yang, Hwai-I Peng, Cheng-Yuan Su, Chien-Wei TUNG-HUNG SU Hu, Tsung-Hui Yu, Ming-Lung HUNG-CHIH YANG Wu, Jaw-Ching |
關鍵字: | Antiviral therapy; Benefits; Family history; Gray zone; Hepatitis B virus; Hepatocellular carcinoma; Noncirrhosis; prediction; Risk score; Treatment guidelines | 公開日期: | 十二月-2021 | 出版社: | SPRINGER | 卷: | 15 | 期: | 6 | 起(迄)頁: | 1421 | 來源出版物: | Hepatology international | 摘要: | ALT ≥ 80 U/L and HBV DNA ≥ 2000 IU/ml are treatment criteria of APASL guidelines for chronic hepatitis B (CHB) patients. The need of antiviral therapy for patients in gray zone (ALT < 80 U/L or HBV DNA < 2000 IU/ml) is controversial. This study aimed to develop a scoring system to predict hepatocellular carcinoma (HCC) and evaluate the benefit of antiviral therapy in these patients. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/623271 | ISSN: | 1936-0533 | DOI: | 10.1007/s12072-021-10263-x |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。